A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies

A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies

Abstract Background The economic burden of interstitial lung disease (ILD) is unknown, limiting informed resource allocation and planning. We sought to conduct the first systematic review on the direct, indirect, and overall costs associated with ILD and to evaluate the cost-effectiveness of current...

Full description

Bibliographic Details
Main Authors: Alyson W. Wong, John Koo, Christopher J. Ryerson, Mohsen Sadatsafavi, Wenjia Chen
Format: Article
Language:English
Published: BMC 2022-04-01
Series:BMC Pulmonary Medicine
Subjects:
Lung diseases, interstitial
Costs and cost analysis
Online Access:https://doi.org/10.1186/s12890-022-01922-2

Internet

https://doi.org/10.1186/s12890-022-01922-2

Similar Items